Prolonged delay in GSK vaccine supply may cost ₩30 bil

By | translator Alice Kang

21.11.20 06:00:53

가나다라 0

Supply suspended for 9 types of vaccines including Rotarix due to misdocumentation… cross-inoculation is being recommended

May cause a 6-month long gap at maximum… ‘domino effect’ may be caused if demand focuses on alternatives and cause disruption in their supply as well

The discontinuation in the supply of many GSK vaccines is causing greater ripples. With the rising possibility that the situation may be prolonged, concerns continue over the sales gap, and procurement of substitutes is rising.

GSK had announced the supply setbacks of 9 of its vaccines to primary clinics and hospitals on the 25th. The vaccines that were discontinued include: ▲Rotarix (rotavirus vaccine), ▲Cervarix (cervical cancer vaccine), ▲Synflorix (Pneumococcal conjugate vaccine), ▲Manveo (meningococcal conjugate vaccine), ▲Havrix (Hepatitis A vaccine), ▲Priorix (MMR vaccine), ▲Boostrix (Tdap vaccine), ▲Infanrix-IPV, IPV/Hib (DTaP vaccine)

The supply of the vaccines was susp

(same@dailypharm.com)

If you want to see the full article, please JOIN US (click)